Implanon: a review of the literature with recommendations for clinical management

J Midwifery Womens Health. 2009 Mar-Apr;54(2):142-9. doi: 10.1016/j.jmwh.2008.09.004.

Abstract

Implanon is a new implantable, progestin-only contraceptive which was approved in the United States in July 2006. Implanon is comprised of a single ethylene vinylacetate copolymer rod that is 4 cm long and 2 mm in diameter. It is inserted subdermally in the groove between the biceps and triceps of the nondominant arm. A literature review was conducted and side effects are discussed. Implanon offers promise as a high-efficacy, long-term contraceptive and can enhance the contraceptive options offered by the women's health care providers. Clinical trial data indicate that the device is both safe and effective.

Publication types

  • Review

MeSH terms

  • Contraceptive Agents, Female* / adverse effects
  • Contraceptive Agents, Female* / pharmacology
  • Desogestrel* / adverse effects
  • Desogestrel* / pharmacology
  • Drug Implants
  • Female
  • Humans
  • Menstruation Disturbances / chemically induced
  • United States

Substances

  • Contraceptive Agents, Female
  • Drug Implants
  • etonogestrel
  • Desogestrel